Gregor Siebert

Director/Board Member at PAION AG

Health Technology

Consumer Services

Profile

Gregor Siebert is Director at BBS-Bioactive Bone Substitutes Plc since 2024.
Mr. Siebert is Member-Supervisory Board at PAION AG since 2023.
Formerly, Mr. Siebert was Head-Marketing & Sales at curasan AG from 2015 to 2021.
Mr. Siebert also was Head-Marketing & Sales at G.L.
Pharma GmbH.
Mr. Siebert completed undergraduate studies at the University of Bonn.

Gregor Siebert active positions

Companies	Position	Start
PAION AG	Director/Board Member	2023-09-29
BBS-BIOACTIVE BONE SUBSTITUTES OYJ	Director/Board Member	2024-05-31

All active positions of Gregor Siebert

Former positions of Gregor Siebert

Companies	Position	End
CURASAN AG	Sales & Marketing	2021-11-30
G.L. Pharma GmbH G.L. Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Sales & Marketing	-

See the detail of Gregor Siebert's experience

Training of Gregor Siebert

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gregor Siebert's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
PAION AG PAION AG Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries develops and commercializes specialty pharmaceutical products	Health Technology
curasan AG curasan AG Medical SpecialtiesHealth Technology Develops, manufactures and distributes biomaterials for bone & tissue regeneration	Health Technology
University of Bonn University of Bonn Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
G.L. Pharma GmbH G.L. Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Health Technology
BBS-Bioactive Bone Substitutes Plc BBS-Bioactive Bone Substitutes Plc Medical SpecialtiesHealth Technology Develops and manufactures bioactive bone substitute implants	Health Technology